US Tissue Banks Supply Cadaver Skin for South Korean Anti-Aging Injections

US tissue banks are supplying donated human cadaver tissue to biotech companies in South Korea. This tissue is used to create Elravie Re20, an anti-ageing injection distributed in South Korea by Humedix. The tissue is derived from the skin of deceased US citizens and is transported from American tissue banks to South Korean biotech companies.

The trade involves high-value biological materials, with the donated skin being valued at tens of millions of dollars. This supply chain links American tissue banks to the global cosmetic industry, which is increasingly moving toward regenerative therapies.